Intellectual Property Cases filed in Delaware
Cases 1 - 10 of 55
H. Lundbeck A/S et al v. Lupin Limited, et al We have downloadable decisions or orders for this case
as 1:2018cv00088
Counter Defendant: Takeda Pharmaceutical Company Ltd.
Plaintiff: Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant: Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant: Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
New York University v. ResMed Inc.
as 1:2021cv00813
Defendant: ResMed Inc.
Plaintiff: New York University
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Amneal Pharmaceuticals et al We have downloadable decisions or orders for this case
as 1:2016cv00853
Defendant: Aurobindo Pharma Ltd, Cadila Healthcare Ltd. doing business as Zydus Cadila, Hetero USA Inc. and others
Plaintiff: Amgen Inc.
3Rd Party Defendant: Alkem Laboratories Ltd. and Ascend Laboratories, LLC
Counter Claimant: Cadila Healthcare Ltd.
Cause Of Action: 35 U.S.C. § 271
Intercept Pharmaceuticals, Inc. et al v. Amneal Pharmaceuticals LLC et al
as 1:2020cv01154
Defendant: Amneal Pharmaceuticals Company GmbH, Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC and others
Plaintiff: Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Limited
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Amneal Pharmaceuticals LLC et al
as 1:2020cv01297
Defendant: Amneal Pharmaceuticals, Inc., Amneal EU, Ltd., Amneal Pharmaceuticals of New York, LLC and others
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Amneal Pharmaceuticals LLC et al
as 1:2016cv00925
Plaintiff: Amgen Inc.
Defendant: Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Co. India Private Limited and Amneal Pharmaceuticals of New York LLC
Cause Of Action: 35 U.S.C. § 271
The Trustees of Columbia University in the City of New York et al v. Illumina, Inc. We have downloadable decisions or orders for this case
as 1:2019cv01681
Plaintiff: QIAGEN Sciences, LLC and The Trustees of Columbia University in the City of New York
Defendant: Illumina, Inc.
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. Amneal Pharmaceuticals Company GmbH et al
as 1:2019cv00712
Defendant: Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceutical Holding Company LLC, Amneal Biosciences LLC and others
Plaintiff: Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC
Cause Of Action: 35 U.S.C. § 271
In re: Rembrandt Technologies LP Patent Litigation Featured Case
as 1:2007md01848
In Re: Rembrandt Technologies LP Patent Litigation
Defendant: Adelphia Communications Corporation; Century-TCI California, LP; Century-TCI California Communications, LP; Century-TCI Distribution Company, LLC; Century-TCI Holdings, LLC; Parnassos, LP; Parnassos C, Cox Communications, Inc., Cox Enterprises, Inc. and others
Counter Defendant: Rembrandt Technologies, LLC d/b/a Remstream
Not Classified By Court: Clerk Jeffery N. Luthi, Rembrandt Technologies LP, Cablevision Systems Corporation and others
Cause Of Action: 28 U.S.C. § 1338
Genentech, Inc. et al v. Amneal Pharmaceuticals LLC et al
as 1:2019cv00190
Plaintiff: Genentech, Inc. and InterMune, Inc.
Defendant: Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York LLC
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?